Dietary Qiwenghuangbo powder–enriched Limosilactobacillus reuteri protects the intestinal epithelium and alleviates inflammation via a strain-specific mechanism

Abstract

Background: Qiwenghuangbo powder (QP), composed of Astragalus, Phellodendron chinensis, and Radix pulsatilla, is a traditional Chinese herbal formula, but its effects on weaned piglets remained unclear.

Methods: Weaned piglets fed with 0.5 kg/t QP (QP1), 1 kg/t QP (QP2), low-zinc oxide (ZnO; negative control), and high-ZnO (positive control) diets in two phases, respectively, and the growth performance, intestinal morphology, cytokines, and microbial communities were profiled. The mouse models of colitis induced by Citrobacter rodentium and dextran sulfate sodium (DSS) were employed to elucidate the potential role of QP-fed enriched key species.

Results: Dietary 1.0 kg/t QP alleviated diarrhea and inflammation and improved intestinal development and growth performance of weaned piglets. Moreover, this dietary intervention notably altered microbiota composition, characterized by the enrichment of Limosilactobacillus reuteri. Furthermore, out of three isolated L. reuteri, two strains could alleviate pathogen infection and intestinal inflammation, respectively. Specifically, the anti-inflammatory effect of one strain was achieved by promoting the colonization resistance of C. rodentium as significantly reduced pathogen loads. The other strain mitigated DSS-induced colitis by enhancing the goblet cell function and inhibiting the secretion of pro-inflammatory cytokines, particularly interleukin-1β (IL-1ß) and tumor necrosis factor-α (TNF-α).

Conclusions: Dietary QP improved the growth performance and intestinal health of weaned piglets by promoting the colonization of L. reuteri. The isolated commensal L. reuteri control colitis in a strain-specific mechanism, highlighting the potential of QP and L. reuteri in providing evidence for gut health promotion.

Keywords

gut microbiome / intestinal inflammation / Limosilactobacillus reuteri / Qiwenghuangbo powder / weaned piglets

References

[1] Lallès JP, Bosi P, Smidt H, Stokes CR. Nutritional management of gut health in pigs around weaning. Proc Nutr Soc. 2007; 66: 260-268.

[2] Pié S, Lallès JP, Blazy F, Laffitte J, Sève B, Oswald IP. Weaning is associated with an upregulation of expression of inflammatory cytokines in the intestine of piglets. J Nutr. 2004; 134: 641-647.

[3] Frese SA, Parker K, Calvert CC, Mills DA. Diet shapes the gut microbiome of pigs during nursing and weaning. Microbiome. 2015; 3: 1-10.

[4] Li Y, Shi P, Yao K, et al. Diarrhea induced by insufficient fat absorption in weaned piglets: causes and nutrition regulation. Anim Nutr. 2024; 16: 299-305.

[5] Shelton NW, Tokach MD, Nelssen JL, et al. Effects of copper sulfate, tri-basic copper chloride, and zinc oxide on weanling pig performance. J Anim Sci. 2011; 89: 2440-2451.

[6] Peng P, Chen J, Yao K, Yin Y, Long L, Fang R. The effects of dietary supplementation with porous zinc oxide on growth performance, intestinal microbiota, morphology, and permeability in weaned piglets. Anim Sci J. 2019; 90: 1220-1228.

[7] Poulsen H. Zinc and copper as feed additives, growth factors or unwanted environmental factors. J Anim Feed Sci. 1998; 7: 135-142.

[8] Gong J, Yin F, Hou Y, Yin Y. Review: Chinese herbs as alternatives to antibiotics in feed for swine and poultry production: potential and challenges in application. Can J Anim Sci. 2014; 94: 223-241.

[9] Zhao L, Zhao J, Bai Z, et al. Polysaccharide from dandelion enriched nutritional composition, antioxidant capacity, and inhibited bioaccumulation and inflammation in Channa asiatica under hexavalent chromium exposure. Int J Biol Macromol. 2022; 201: 557-568.

[10] Fu J, Wang Z, Huang L, et al. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res. 2014; 28(9): 1275-1283.

[11] Yang C, Han Q, Wang K, Xu Y, Lan J, Cao G. Astragalus and ginseng polysaccharides improve developmental, intestinal morphological, and immune functional characters of weaned piglets. Front Physiol. 2019; 10: 1-11.

[12] Huang K. The Pharmacology of Chinese Herbs. CRC Press; 1993.

[13] Xian Y, Mao Q, Ip S, Lin Z, Che C. Comparison on the anti-inflammatory effect of Cortex Phellodendri chinensis and Cortex Phellodendri amurensis in 12-O-tetradecanoyl-phorbol-13-acetate-induced ear edema in mice. J Ethnopharmacol. 2011; 137: 1425-1430.

[14] Xu Q, Chen Z, Ding X, et al. Three new triterpenoids from Pulsatilla chinensis (Bunge) Regel and their cytotoxic activities. Heterocycles. 2011; 83(10): 2365-2372.

[15] Liu Y, Zhou M, Yang M, et al. Pulsatilla chinensis saponins ameliorate inflammation and DSS-induced ulcerative colitis in rats by regulating the composition and diversity of intestinal flora. Front Cell Infect Microbiol. 2021; 11: 728929.

[16] Wang L, Zhou G, Liu P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA. 2008; 105(12): 4826-4831.

[17] Xu Q, Cheng M, Jiang R, et al. Effects of dietary supplement with a Chinese herbal mixture on growth performance, antioxidant capacity, and gut microbiota in weaned pigs. Front Vet Sci. 2022; 9: 971647.

[18] Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity. 2017; 46: 562-576.

[19] Kamada N, Seo SU, Chen GY, Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013; 13: 321-335.

[20] Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019; 16: 605-616.

[21] Tsai YL, Lin TL, Chang CL, et al. Probiotics, prebiotics and amelioration of diseases. J Biomed Sci. 2019; 26(1): 3.

[22] Wu Z, Huang S, Li T, et al. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome. 2021; 9: 184.

[23] Fan L, Xia L, Wang Y, et al. Gut microbiota bridges dietary nutrients and host immunity. Sci China Life Sci. 2023; 66(11): 2466-2514.

[24] Han D, Wu Y, Lu D, et al. Polyphenol-rich diet mediates interplay between macrophage-neutrophil and gut microbiota to alleviate intestinal inflammation. Cell Death Dis. 2023; 14: 656.

[25] Pi Y, Wu Y, Zhang X, et al. Gut microbiota-derived ursodeoxycholic acid alleviates low birth weight-induced colonic inflammation by enhancing M2 macrophage polarization. Microbiome. 2023; 11: 19.

[26] Wu Y, Liu X, Zou Y, et al. Lactobacillus amylovorus promotes lactose utilization in small intestine and enhances intestinal barrier function in intrauterine growth restricted piglets. J Nutr. 2024; 154: 535-542.

[27] Wu Y, Zhang X, Liu X, et al. Galactooligosaccharides and Limosilactobacillus reuteri synergistically alleviate gut inflammation and barrier dysfunction by enriching Bacteroides acidifaciens for pentadecanoic acid biosynthesis. Nat Commun. 2024; 15: 9291.

[28] Campbell JM, Crenshaw JD, Polo J. The biological stress of early weaned piglets. J Anim Sci Biotechnol. 2013; 4: 19.

[29] EI Aidy S, Van Den Bogert B, Kleerebezem M. The small intestine microbiota, nutritional modulation and relevance for health. Curr Opin Biotechnol. 2015; 32: 14-20.

[30] Gresse R, Chaucheyras-Durand F, Fleury MA, Van de Wiele T, Forano E, Blanquet-Diot S. Gut microbiota dysbiosis in postweaning piglets: understanding the keys to health. Trends Microbiol. 2017; 25: 851-873.

[31] Li Y, Sun T, Hong Y, et al. Mixture of five fermented herbs (Zhihuasi Tk) alters the intestinal microbiota and promotes the growth performance in piglets. Front Microbiol. 2021; 12: 725196.

[32] Canibe N, Højberg O, Kongsted H, et al. Review on preventive measures to reduce post-weaning diarrhoea in piglets. Animals. 2022; 12: 2585.

[33] Xiao C, Li K, Teng C, et al. Dietary qi-Weng-Huangbo powder enhances growth performance, diarrhoea and immune function of weaned piglets by modulating gut health and microbial profiles. Front Immunol. 2023; 14: 1342852.

[34] Liu HY, Giraud A, Seignez C, et al. Distinct B cell subsets in Peyer's patches convey probiotic effects by Limosilactobacillus reuteri. Microbiome. 2021; 9: 198.

[35] Hou C, Zeng X, Yang F, Liu H, Qiao S. Study and use of the probiotic Lactobacillus reuteri in pigs: a review. J Anim Sci Biotechnol. 2015; 6: 6-14.

[36] Wu Y, Zhang X, Liu X, et al. Strain specificity of lactobacilli with promoted colonization by galactooligosaccharides administration in protecting intestinal barriers during salmonella infection. J Adv Res. 2024; 56: 1-14.

[37] Zheng J, Wittouck S, Salvetti E, et al. A taxonomic note on the genus lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol. 2020; 70: 2782-2858.

[38] Matsuda Y, Ozawa N, Shinozaki T, et al. Ergothioneine, a metabolite of the gut bacterium Lactobacillus reuteri, protects against stress-induced sleep disturbances. Transl Psychiatry. 2020; 10: 170.

[39] Walter J, Britton RA, Roos S. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc Natl Acad Sci USA. 2011; 108: 4645-4652.

[40] Higgins LM, Frankel G, Douce G, Dougan G, MacDonald TT. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun. 1999; 67: 3031-3039.

[41] Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. Citrobacter rodentium of mice and man. Cell Microbiol. 2005; 7: 1697-1706.

[42] Hoffmann JC, Pawlowski NN, Höhne W, Zeitz M. Animal models of inflammatory bowel disease: an overview. Pathobiology. 2002; 70: 121-130.

[43] Frese SA, Benson AK, Tannock GW, et al. The evolution of host specialization in the vertebrate gut symbiont Lactobacillus reuteri. PLoS Genet. 2011; 7: e1001314.

[44] Wu J, Lin Z, Wang X, et al. Limosilactobacillus reuteri SLZX19-12 protects the colon from infection by enhancing stability of the gut microbiota and barrier integrity and reducing inflammation. Microb Spectr. 2022; 10(3): e02124-21.

[45] Wiles S, Clare S, Harker J, et al. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol. 2004; 6: 963-972.

[46] Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol. 2004; 70: 1176-1181.

[47] Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases. Front Microbiol. 2018; 9: 757.

[48] Kim JJ, Shajib MS, Manocha MM, Khan WI. Investigating intestinal inflammation in DSS-induced model of IBD. J Vis Exp. 2012;3678.

[49] Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014; 104: 15.25.1-15.25.14.

[50] Casas GA, Blavi L, Cross TL, Lee AH, Swanson KS, Stein HH. Inclusion of the direct-fed microbial Clostridium butyricum in diets for weanling pigs increases growth performance and tends to increase villus height and crypt depth, but does not change intestinal microbial abundance. J Anim Sci. 2020; 98: skz372.

[51] Hansson GC. Mucins and the microbiome. Annu Rev Biochem. 2020; 89: 769-793.

[52] Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal-antibodies prevent septic shock during lethal bacteremia. Nature. 1987; 330: 662-664.

[53] Jones SE, Versalovic J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol. 2009; 9: 1-9.

[54] Li Z, Song Y, Xu W, et al. Pulsatilla chinensis saponins improve SCFAs regulating GPR43-NLRP3 signaling pathway in the treatment of ulcerative colitis. J Ethnopharmacol. 2023; 308: 116215.

[55] Alzoghaibi MA, Al Mofleh IA, Al-Jebreen AM. Lipid peroxides in patients with inflammatory bowel disease. Saudi J Gastroenterol. 2007; 13: 187-190.

[56] Pulli B, Ali M, Forghani R, et al. Measuring myeloperoxidase activity in biological samples. PLoS One. 2013; 8: e67976.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.